Skip to main content
Log in

Current developments in early diagnosis of acute kidney injury

  • Nephrology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Acute kidney injury (AKI) is a very frequent and serious clinical problem, accounting for overall high morbidity and mortality. Up to date, mortality due to AKI is virtually unchanged over the past 50 years. This may partly be explained due to a delay in initiating renal protective and appropriate therapeutic measures since until now there are no reliable early-detecting biomarkers. The gold standard, serum creatinine, displays poor specificity and sensitivity with regard to identification of the incipient phase of AKI, and this is also true for cystatin C. We aimed to review novel biomarkers of AKI in urine and serum which have now progressed to the clinical phase. The main focus refers to their diagnostic and prognostic value. For this purpose, a web-based literature search using PubMed was performed comprising the following terms: renal failure, acute kidney injury and biomarkers. New molecules such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), N-acetyl-β-d-glucosaminidase (NAG), monocyte chemotactic peptide (MCP-1), Il-18, liver-type fatty acid-binding protein (L-FABP) and Netrin-1 are available and represent promising new markers that, however, need to be further evaluated in the clinical setting for suitability. In clinical settings with incipient AKI, not only the development and the implementation of more sensitive, practicable and accurate biomarkers are required for well-timed treatment initiation. Just as important is a substantial improvement of refined and applicable prophylactic therapeutic options in these situations. Before full adoption in clinical practice can be accomplished, adequately powered clinical trials testing a row of biomarkers are strongly warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brar H, Olivier J, Lebrun C et al (2008) Predictors of mortality in a cohort of intensive care unit patients with acute renal failure receiving continuous renal replacement therapy. Am J Med Sci 335:342–347

    Article  PubMed  Google Scholar 

  2. Ympa YP, Sakr Y, Reinhart K et al (2005) Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 118:827–832

    Article  PubMed  Google Scholar 

  3. Nguyen MT, Devarajan P (2008) Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 23:2151–2157

    Article  PubMed  Google Scholar 

  4. Ferguson MA, Vaidya VS, Waikar SS et al (2010) Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 77:708–714

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212

    Article  PubMed  Google Scholar 

  6. Mehta R, Kellum J, Shah S et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31

    Article  PubMed  Google Scholar 

  7. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930–936

    Article  PubMed  Google Scholar 

  8. Bonventre JV (2010) Pathophysiology of AKI: injury and normal and abnormal repair. Contrib Nephrol 165:9–17

    Article  PubMed  Google Scholar 

  9. Humphreys BD, Bonventre JV (2008) Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59:311–325

    Article  CAS  PubMed  Google Scholar 

  10. Chertow GM, Burdick E, Honour M et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365–3370

    Article  PubMed  Google Scholar 

  11. Ozer JS, Dieterle F, Troth S et al (2010) A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 28:486–494

    Article  CAS  PubMed  Google Scholar 

  12. Bonventre JV (2008) Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 241:78–83

    Article  PubMed  Google Scholar 

  13. Mishra J, Ma Q, Prada A et al (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543

    Article  CAS  PubMed  Google Scholar 

  14. Munshi R, Johnson A, Siew ED et al (2011) MCP-1 gene activation marks acute kidney injury. J Am Soc Nephrol 22:165–175

    Article  CAS  PubMed  Google Scholar 

  15. Kamijo A, Sugaya T, Hikawa A et al (2006) Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 284:175–182

    Article  CAS  PubMed  Google Scholar 

  16. Matsui K, Kamijo-Ikemori A, Hara M et al (2011) Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clin Exp Nephrol 15:220–225

    Article  CAS  PubMed  Google Scholar 

  17. Flower DR, North AC, Sansom CE (2000) The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta 1482:9–24

    Article  CAS  PubMed  Google Scholar 

  18. Supavekin S, Zhang W, Kucherlapati R et al (2003) Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63:1714–1724

    Article  CAS  PubMed  Google Scholar 

  19. Haase M, Bellomo R, Devarajan P et al (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54:1012–1024

    Article  CAS  PubMed  Google Scholar 

  20. Soni SS, Cruz D, Bobek I et al (2010) NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 42:141–150

    Article  CAS  PubMed  Google Scholar 

  21. Kiani AN, Wu T, Fang H et al (2012) Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol 39:1231–1237

    Article  PubMed Central  PubMed  Google Scholar 

  22. Ichimura T, Bonventre JV, Bailly V et al (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273:4135–4142

    Article  CAS  PubMed  Google Scholar 

  23. Han WK, Bailly V, Abichandani R et al (2002) Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237–244

    Article  CAS  PubMed  Google Scholar 

  24. Liangos O, Perianayagam MC, Vaidya VS et al (2007) Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury of urinary liver-type fatty acid-bindingmolecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18:904–912

    Article  CAS  PubMed  Google Scholar 

  25. Nejat M, Pickering JW, Devarajan P et al (2012) Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 81:1254–1262

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Luo Q, Zhou F, Dong H et al (2013) Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention. Clin Nephrol 79:85–92

    Article  CAS  PubMed  Google Scholar 

  27. Bonventre JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24:3265–3268

    Article  CAS  PubMed  Google Scholar 

  28. Bernard AM, Vyskocil AA, Mahieu P et al (1987) Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 33:775–779

    CAS  PubMed  Google Scholar 

  29. Price RG (1992) The role of NAG (N-acetyl-beta-d-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 38(Suppl 1):S14–S19

    PubMed  Google Scholar 

  30. Marchewka Z, Kuzniar J, Dlugosz A (2001) Enzymuria and beta2-mikroglobulinuria in the assessment of the influence of proteinuria on the progression of glomerulopathies. Int Urol Nephrol 33:673–676

    Article  CAS  PubMed  Google Scholar 

  31. Katagiri D, Doi K, Honda K (2012) Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg 93:577–583

    Article  PubMed  Google Scholar 

  32. Rice JC, Spence JS, Yetman DL et al (2002) Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Ren Fail 24:703–723

    Article  CAS  PubMed  Google Scholar 

  33. Gauer S, Sichler O, Obermuller N et al (2007) IL-18 is expressed in the intercalated cell of human kidney. Kidney Int 72:1081–1087

    Article  CAS  PubMed  Google Scholar 

  34. Parikh CR, Jani A, Melnikov VY et al (2004) Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 43:405–414

    Article  CAS  PubMed  Google Scholar 

  35. Manabe K, Kamihata H, Motohiro M et al (2012) Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest 42:557–563

    Article  CAS  PubMed  Google Scholar 

  36. Przybylowski P, Koc-Zorawska E, Malyszko JS et al (2011) Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function. Transplant Proc 43:3064–3067

    Article  CAS  PubMed  Google Scholar 

  37. Matsui K, Kamijo-Ikemori A, Sugaya T et al (2012) Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults. Circ J 76:213–220

    Article  CAS  PubMed  Google Scholar 

  38. Portilla D, Dent C, Sugaya T et al (2008) Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 73:465–472

    Article  CAS  PubMed  Google Scholar 

  39. Susantitaphong P, Siribamrungwong M, Doi K (2013) Performance of urinary liver-typy acid-binding protein in acute kidney injury: a meta-analysis. Am J Kidney Dis 61:430–439

    Article  CAS  PubMed  Google Scholar 

  40. Reeves WB, Kwon O, Ramesh G (2008) Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol 294:F731–F738

    Article  CAS  PubMed  Google Scholar 

  41. Ramesh G, Krawczeski CD, Woo JG et al (2010) Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 5:395–401

    Article  CAS  PubMed  Google Scholar 

  42. Ramesh G, Kwon O, Ahn K (2010) Netrin-1: a novel universal biomarker of human kidney injury. Transplant Proc 42:1519–1522

    Article  CAS  PubMed  Google Scholar 

  43. Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas Obermüller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Obermüller, N., Geiger, H., Weipert, C. et al. Current developments in early diagnosis of acute kidney injury. Int Urol Nephrol 46, 1–7 (2014). https://doi.org/10.1007/s11255-013-0448-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-013-0448-5

Keywords

Navigation